Search

everythinglearnresearchcommunity

for

Search:↓

The new treatment regimen was effective in promoting significant hair growth in all 15 male patients with androgenic alopecia.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

A gel with dutasteride and 10% garlic extract may effectively treat male pattern baldness.

A reliable method was created to measure dutasteride and related molecules in capsules.

Mouse skin can produce and process serotonin, with variations depending on hair cycle, body location, and mouse strain.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

High levels of ODC and a mutant Ha-ras gene cause tumors in mice.

The improved process makes Finasteride suitable for industrial production.

The S9 fraction with GC-IDMS is effective for measuring 5α-reductase activity.

Editing the FGF5 gene in sheep increases wool length, confirming its role in hair growth.

New SRD5A2 variants may disrupt protein function, aiding diagnosis and treatment of related disorders.

The compounds tested could potentially treat hair loss and alopecia.

Methylated gene parts may cause finasteride-resistance in some enlarged prostate patients.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

The role of 5α-reductase-3 in prostate cancer is unclear and needs more research.

Beard hair follicles convert testosterone to 5α-dihydrotestosterone most intensively.

Sex steroids influence skin appendage function and neoplasm development, with changes in AR and ERalpha in certain gland neoplasms.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Clascoterone may be a promising treatment for hair loss.

Dutasteride is more effective than finasteride for hair growth, and pregabalin effectively treats neuropathic pain.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

A new method was developed to make finasteride for treating hair loss.

Researchers found two enzymes in Avicennia marina that help produce maslinic acid and corosolic acid, which have medicinal benefits.

Taking medication for hair loss might cause sexual problems.